News
An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...
At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...
Health and Me on MSN4d
FDA Panel Questions Antidepressant Safety For Pregnant Women; Can SSRIs Harm Unborn Babies?When the U.S. Food and Drug Administration (FDA) convened a public expert panel to review the use of selective serotonin ...
On Monday morning, the FDA hosted a 10-person expert panel on the use during pregnancy of SSRIs, which include medications ...
Experts on the panel shared many of the same views around SSRIs, arguing the risks of the drugs during pregnancy are greater ...
A Food and Drug Administration panel on Monday discussing the use of antidepressants during pregnancy largely amounted to ...
Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...
As my colleague Kiera Butler has written, Kennedy has claimed, without evidence, that they can cause addiction and school ...
A House subcommittee will hold a hearing today covering safety lapses and improvements to be made to the organ donor system. In other news: the FDA's debate on antidepressant use during pregnancy; the ...
August 24, 2010 — A new review of 4 meta-analyses of efficacy trials submitted to the US Food and Drug Administration (FDA) suggests that antidepressants are only "marginally efficacious" compared ...
NBC News medical contributor Dr. Natalie Azar reports on the FDA panel discussion of the use of antidepressants during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback